| Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease (NCT00744978) | Pfizer | 2009-07-01 |
| A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease (NCT00937352) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2009-07-01 |
| Hormone and Information Processing Study (NCT00539305) | University of Washington | 2009-07-01 |
| A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers (NCT00931073) | Pfizer | 2009-07-01 |
| Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia (NCT00966017) | National Institute on Aging (NIA) | 2009-07-01 |
| Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease (NCT00888056) | Centre Hospitalier Universitaire de Nice | 2009-06-01 |
| Efficacy and Safety of Filgrastim in Alzheimer's Disease (NCT01617577) | University of South Florida | 2009-06-01 |
| QTc Study of Rosi XR in Healthy Volunteers (NCT00884533) | GlaxoSmithKline | 2009-06-01 |
| Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients (NCT01312363) | Seoul National University Hospital | 2009-06-01 |
| A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease (NCT00890890) | Bristol-Myers Squibb | 2009-05-01 |
| A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease (NCT00884507) | Hoffmann-La Roche | 2009-05-01 |
| Non-Interventional Study With Aricept® Evess (NCT00889603) | Pfizer | 2009-05-01 |
| Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease (NCT00901498) | Bristol-Myers Squibb | 2009-05-01 |
| Effect of LY2062430 on the Progression of Alzheimer's Disease (NCT00904683) | Eli Lilly and Company | 2009-05-01 |
| Effect of LY2062430 on the Progression of Alzheimer's Disease (NCT00905372) | Eli Lilly and Company | 2009-05-01 |
| Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's (NCT00980785) | University of Wisconsin, Madison | 2009-04-09 |
| A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) (NCT00874939) | Merck Sharp & Dohme LLC | 2009-04-06 |
| Effects of Exercise Training in Patients With Mild Cognitive Impairment (NCT01724151) | National Taiwan University Hospital | 2009-04-01 |
| Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease (NCT02708485) | Université de Sherbrooke | 2009-04-01 |
| FluoroAv45 Imaging Research-in Alzheimer's Disease (NCT01325259) | University Hospital, Tours | 2009-04-01 |
| Wii-fit for Activity, Balance and Gait in Assisted Living (NCT01000038) | University of Nebraska | 2009-03-30 |
| Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals (NCT00855868) | Avid Radiopharmaceuticals | 2009-03-01 |
| Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease (NCT00886951) | Institute for Neurodegenerative Disorders | 2009-03-01 |
| Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease (NCT01095744) | Institut National de la Santé Et de la Recherche Médicale, France | 2009-03-01 |
| A Safety and Tolerability Study of ABT-126 in Elderly (NCT00867399) | Abbott | 2009-03-01 |
| A Composite MR Neuroimaging Marker for Alzheimer's Disease (NCT01615666) | Medical College of Wisconsin | 2009-03-01 |
| Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil (NCT00829374) | Medivation, Inc. | 2009-03-01 |
| Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease (NCT00939822) | University of Wisconsin, Madison | 2009-03-01 |
| Development and Decline of Brain and Cognition Through the Life Span (NCT00880451) | National Institute of Mental Health (NIMH) | 2009-03-01 |
| A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects (NCT00825084) | Pfizer | 2009-02-01 |
| Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease (NCT00965588) | United Biomedical | 2009-02-01 |
| Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease (NCT00842816) | Sonexa Therapeutics, Inc. | 2009-02-01 |
| Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease (NCT00842673) | Sonexa Therapeutics, Inc. | 2009-02-01 |
| Treatment for Aggression and Agitation in Patients With Alzheimer's Disease (NCT00843518) | Eli Lilly and Company | 2009-02-01 |
| A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease (NCT00810147) | Bristol-Myers Squibb | 2009-02-01 |
| A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects (NCT00827034) | Pfizer | 2009-02-01 |
| A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function (NCT00824590) | Pfizer | 2009-02-01 |
| Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease (NCT00812565) | Octapharma | 2009-02-01 |
| Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid (NCT00838877) | AstraZeneca | 2009-01-01 |
| A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study (NCT00809510) | Abbott | 2009-01-01 |
| Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45) (NCT00857506) | Avid Radiopharmaceuticals | 2009-01-01 |
| Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects (NCT00870519) | Institute for Neurodegenerative Disorders | 2009-01-01 |
| Dominantly Inherited Alzheimer Network (DIAN) (NCT00869817) | Washington University School of Medicine | 2009-01-01 |
| COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE (NCT02860338) | Clionsky Neuro Systems Inc. | 2009-01-01 |
| Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly (NCT00954616) | University Hospital, Limoges | 2009-01-01 |
| A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease (NCT00818662) | Baxalta now part of Shire | 2008-12-19 |
| Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease (NCT00722046) | Pfizer | 2008-12-05 |
| A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED) (NCT00777608) | Merck Sharp & Dohme LLC | 2008-12-01 |
| Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain (NCT00857415) | Avid Radiopharmaceuticals | 2008-12-01 |
| Pharmacokinetic Interaction Between AZD3480 and Donepezil (NCT00713765) | AstraZeneca | 2008-12-01 |
| The Trinity, Ulster and Department of Agriculture Cohort Study (NCT02664584) | University of Ulster | 2008-12-01 |
| Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease (NCT00948259) | Noscira SA | 2008-12-01 |
| Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil (NCT00829816) | Medivation, Inc. | 2008-12-01 |
| A Safety Study of LY2811376 Single Doses in Healthy Subjects (NCT00838084) | Eli Lilly and Company | 2008-12-01 |
| Memantine and Validation of a New Alzheimer's Disease Scale (NCT00804271) | Merz Pharmaceuticals GmbH | 2008-12-01 |
| Exelon Patch and Combination With Memantine Comparative Trial (NCT01025466) | Inha University Hospital | 2008-12-01 |
| Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease (NCT00814697) | The New York Memory Services | 2008-12-01 |
| Improving Function, Quality of Life, Glycemia in Diabetics With Dementia (NCT00792662) | University of Nebraska | 2008-11-18 |
| Implications of Amyloid Pathology (NCT00900770) | National Institute on Aging (NIA) | 2008-11-01 |
| Long-term Safety and Tolerability of AFFITOPE AD02 (NCT00711321) | Affiris AG | 2008-11-01 |
| Alzheimer and Sleep (NCT00750529) | University Hospital, Clermont-Ferrand | 2008-11-01 |
| Progression Delaying Effect of Escitalopram in Alzheimer's Disease (NCT00702780) | Seoul National University Hospital | 2008-11-01 |
| Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease (NCT00753662) | Tel-Aviv Sourasky Medical Center | 2008-11-01 |
| Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease (NCT00876863) | Sangamo Therapeutics | 2008-11-01 |
| Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions (NCT00814346) | Ipsen | 2008-10-01 |
| Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease (NCT00766363) | FORUM Pharmaceuticals Inc | 2008-10-01 |
| Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers (NCT00777361) | AstraZeneca | 2008-10-01 |
| Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients (NCT00795418) | Novartis | 2008-10-01 |
| Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers (NCT00785759) | GE Healthcare | 2008-09-01 |
| Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease (NCT00749216) | Eli Lilly and Company | 2008-09-01 |
| Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo (NCT00762411) | Eli Lilly and Company | 2008-09-01 |
| PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers (NCT00733785) | GlaxoSmithKline | 2008-08-13 |
| A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease (NCT00736775) | Genentech, Inc. | 2008-08-01 |
| Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease (NCT00733642) | Pfizer | 2008-08-01 |
| A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease (NCT01320527) | University of Massachusetts, Worcester | 2008-08-01 |
| Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease (NCT00708552) | GlaxoSmithKline | 2008-07-04 |
| Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. (NCT00731224) | Novartis Pharmaceuticals | 2008-07-01 |
| Memantine and Antipsychotics Use (NCT00649220) | Merz Pharmaceuticals GmbH | 2008-07-01 |
| A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease (NCT00710684) | GlaxoSmithKline | 2008-07-01 |
| Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment (NCT00684281) | Assistance Publique Hopitaux De Marseille | 2008-07-01 |
| Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI) (NCT00714571) | VA Office of Research and Development | 2008-07-01 |
| Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease (NCT00800709) | Shanghai Mental Health Center | 2008-07-01 |
| Passport to Brain Wellness in Sedentary Adults (NCT00979446) | HealthPartners Institute | 2008-06-01 |
| A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease (NCT00679627) | Janssen Research & Development, LLC | 2008-06-01 |
| A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease (NCT01478204) | Janssen-Cilag, S.A. | 2008-06-01 |
| Long-term Safety and Tolerability of AFFITOPE AD01 (NCT00711139) | Affiris AG | 2008-06-01 |
| Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease (NCT00691340) | University Hospital, Basel, Switzerland | 2008-06-01 |
| A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) (NCT00702143) | Avid Radiopharmaceuticals | 2008-06-01 |
| MRI to Measure Treatment With Antibiotics in Alzheimer's Disease (NCT00692588) | St. Joseph's Healthcare Hamilton | 2008-06-01 |
| A Pilot Study of Inflammatory Markers in Alzheimer's Disease (NCT00715858) | McMaster University | 2008-05-01 |
| Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease (NCT00693004) | Epix Pharmaceuticals, Inc. | 2008-05-01 |
| A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease (NCT00675623) | Medivation, Inc. | 2008-05-01 |
| Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition (NCT00968097) | Institute for Neurodegenerative Disorders | 2008-04-01 |
| Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease (NCT00704782) | Medivation, Inc. | 2008-04-01 |
| Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test (NCT00666445) | Orasi Medical, Inc. | 2008-04-01 |
| A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers (NCT01565343) | Avid Radiopharmaceuticals | 2008-04-01 |
| Imaging of Brain Amyloid Plaques in the Aging Population (NCT00950430) | Mayo Clinic | 2008-04-01 |
| A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease (NCT00880412) | Exonhit | 2008-04-01 |
| A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil (NCT00672945) | Epix Pharmaceuticals, Inc. | 2008-04-01 |
| Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) (NCT00908999) | University of Wisconsin, Madison | 2008-04-01 |